Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04177511

Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
72 (estimated)
Sponsor
Hopital Foch · Academic / Other
Sex
Female
Age
15 Years
Healthy volunteers
Not accepted

Summary

6-10% of women of childbearing age suffer from endometriosis, which is mainly manifested by dysmenorrhea, non-menstrual pelvic pain and dyspareunia. Several treatment strategies, including surgical ones, are proposed but they are sometimes insufficient because endometriosis-related pain is frequently accompanied by sensitization. Endometriosis surgery, when indicated, is therefore changeably effective, even though the lesions have been completely resected. Patients therefore consult Pain Units seeking for the effective treatment as the pain persist even after surgical management of endometriosis. Vagus nerve stimulation is a non-invasive technique that includes an anti-inflammatory effect and a modulation of neurotransmitter production (adrenaline, norepinephrine; serotonin, acetylcholine). Yuan and Silberstein published a general review on the technique. Migraine and depression are one of the selected indications. In addition, Napadow et al. published favourable results in a short series of patients with chronic pelvic pain. The Investigators of this study have treated some patients with this technique with a result deemed satisfactory which leads to propose a randomized study to confirm this impression.

Conditions

Interventions

TypeNameDescription
DEVICETranscutaneous Auricular Vagus Nerve StimulationTranscutaneous Auricular Vagus Nerve Stimulation has an eartip connected to an external stimulator. The device used in this study is the TENS Eco Plus commercialized by Schwa Medico and European Compliance (CE) marked. The electrode is positioned in the cymba concha of the left ear.

Timeline

Start date
2021-12-13
Primary completion
2027-03-28
Completion
2027-03-28
First posted
2019-11-26
Last updated
2025-11-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04177511. Inclusion in this directory is not an endorsement.